Mangoceuticals, Inc.
MGRX
$0.04
Change (1 day)
$16.80
Year High
$2.10
Year Low
Categories
Mangoceuticals, Inc. focuses on develops, markets, and sells various men's wellness products and services through a telemedicine platform. It offers erectile dysfunction products under the Mango brand name. The company sells its products through online website mangorx.com. Mangoceuticals, Inc. was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. operates as a subsidiary of Cohen Enterprises, Inc.
Earnings for Mangoceuticals, Inc. (MGRX)
Earnings in 2023 (TTM): $-9,212,417
According to Mangoceuticals, Inc.'s latest financial reports the company's current earnings (TTM) are $-9,212,417. The earnings displayed on this page is the company's Pretax Income.
Earnings history of Mangoceuticals, Inc.
Annual Earnings
| Year | Income Before Tax | Net Income |
|---|---|---|
| 2023 | $-9,212,417 | $-9,212,417 |
| 2022 | $-1,998,055 | $-1,998,055 |
| 2021 | $-17,701 | $-17,701 |